Family Medicine · Hermitage, PA
NPI
1558324814
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
480 N Kerrwood Dr, Suite 102
Hermitage, PA, 16148
Phone (724) 981-0823
Groups this clinician bills Medicare through
Medicare paid, 2024
$224K
6,273 services
Medicare patients, 2024
437
Average age 76
Drug cost, 2024
$2.6M
27,237 prescriptions
Company payments, 2025
$2,214
From 26 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Charles E D'Auria was code J0897 (injection, denosumab, 1 mg), 2,700 times for 26 patients. In total Charles E D'Auria billed 6,273 services in 47 codes, and Medicare paid $224K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-07-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 2,700 | 26 | $20.52 | $55K |
| 99213 Office E&M - Established | Office | 1,123 | 332 | $56.29 | $63K |
| 99441 Telephone Services | Office | 230 | 131 | $33.96 | $7,812 |
| 99231 Hospital E&M - Subsequent | Facility | 193 | 55 | $34.56 | $6,670 |
| 99347 Home E&M - New and Established | Office | 177 | 16 | $27.11 | $4,798 |
| G0008 Administration of influenza virus vaccine | Office | 158 | 157 | $30.58 | $4,831 |
| 90658 Vaccine Product | Office | 157 | 156 | $21.42 | $3,363 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 154 | 52 | $0.67 | $103 |
| 99307 SNF E&M | Facility | 151 | 39 | $24.03 | $3,629 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 148 | 148 | $114.71 | $17K |
| 99214 Office E&M - Established | Office | 137 | 92 | $80.55 | $11K |
| 99232 Hospital E&M - Subsequent | Facility | 134 | 61 | $54.59 | $7,315 |
| 99223 Hospital E&M - Initial | Facility | 93 | 67 | $118.53 | $11K |
| 93000 Electrocardiogram | Office | 83 | 69 | $9.14 | $759 |
| 99239 Hospital Discharge Management | Facility | 78 | 52 | $79.85 | $6,228 |
By year: 2022 $278K for 7,029 services; 2023 $275K for 6,940 services; 2024 $224K for 6,273 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82270 Immunoassay | 53 | 53 | $4.29 | $227 |
Medicare prescription drug claims, 2024
In 2024, the drug Charles E D'Auria prescribed most often to Medicare patients was Levothyroxine Sodium, with 1,372 prescriptions and refills. In total Charles E D'Auria wrote 27,237 Medicare prescriptions that cost $2.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 1,372 | 3,010 | 289 | $12K |
| Atorvastatin Calcium Generic | 1,359 | 3,182 | 338 | $12K |
| Pantoprazole Sodium Generic | 1,006 | 2,191 | 275 | $12K |
| Amlodipine Besylate Generic | 910 | 2,335 | 242 | $5,017 |
| Potassium Chloride Generic | 873 | 1,680 | 207 | $22K |
| Omeprazole Generic | 614 | 1,263 | 138 | $5,437 |
| Prednisone Generic | 608 | 701 | 365 | $2,007 |
| Rosuvastatin Calcium Generic | 562 | 1,374 | 153 | $6,845 |
| Eliquis Apixaban | 554 | 785 | 89 | $404K |
| Metformin Hcl Generic | 543 | 1,296 | 133 | $3,874 |
| Metoprolol Tartrate Generic | 527 | 1,129 | 117 | $3,219 |
| Metoprolol Succinate Generic | 513 | 1,160 | 128 | $6,205 |
| Losartan Potassium Generic | 444 | 1,137 | 121 | $4,491 |
| Lisinopril Generic | 439 | 1,049 | 109 | $2,796 |
| Gabapentin Generic | 413 | 741 | 114 | $13K |
Brand drugs: 3,421 claims; generic drugs: 23,727 claims; opioid claims: 347.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Charles E D'Auria $2,214 ($2,214 in general payments such as food, travel and fees) from 26 companies. The largest payer was GlaxoSmithKline, LLC. with $312.
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. GSK | 18 | $312 |
| Abbvie Inc. ABBV | 19 | $266 |
| Novo Nordisk Inc NVO | 10 | $182 |
| Lundbeck LLC | 12 | $178 |
| Amgen Inc. AMGN | 14 | $167 |
| AstraZeneca Pharmaceuticals LP AZN | 7 | $147 |
| Lilly USA, LLC LLY | 12 | $137 |
| Novartis Pharmaceuticals Corporation NVS | 6 | $99 |
| E.R. Squibb & Sons, L.L.C. BMY | 5 | $86.31 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $82.89 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.